87 related articles for article (PubMed ID: 22142538)
1. Antiangiogenic activity of 3,4-seco-cycloartane triterpenes from Thai Gardenia spp. and their semi-synthetic analogs.
Pudhom K; Nuanyai T; Matsubara K; Vilaivan T
Bioorg Med Chem Lett; 2012 Jan; 22(1):512-7. PubMed ID: 22142538
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic and anti-angiogenic properties of minor 3,4-seco-cycloartanes from Gardenia sootepensis exudate.
Pudhom K; Nuanyai T; Matsubara K
Chem Pharm Bull (Tokyo); 2012; 60(12):1538-43. PubMed ID: 23207634
[TBL] [Abstract][Full Text] [Related]
3. Three new 3,4-seco-cycloartane triterpenes from Gardenia sootepensis.
Song WW; Wang XQ; Jia HL; Zhang ZK; Ding YJ; Chen YH
Nat Prod Res; 2018 Oct; 32(19):2338-2342. PubMed ID: 29251512
[TBL] [Abstract][Full Text] [Related]
4. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic 3,4-seco-cycloartane triterpenes from Gardenia sootepensis.
Nuanyai T; Sappapan R; Teerawatananond T; Muangsin N; Pudhom K
J Nat Prod; 2009 Jun; 72(6):1161-4. PubMed ID: 19456120
[TBL] [Abstract][Full Text] [Related]
6. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile.
Ganesan P; Matsubara K; Ohkubo T; Tanaka Y; Noda K; Sugawara T; Hirata T
Phytomedicine; 2010 Dec; 17(14):1140-4. PubMed ID: 20637577
[TBL] [Abstract][Full Text] [Related]
8. In vitro and ex vivo antiangiogenic activity of Salvia officinalis.
Keshavarz M; Mostafaie A; Mansouri K; Bidmeshkipour A; Motlagh HR; Parvaneh S
Phytother Res; 2010 Oct; 24(10):1526-31. PubMed ID: 20878705
[TBL] [Abstract][Full Text] [Related]
9. Prevention of FGF-2-induced angiogenesis by scopoletin, a coumarin compound isolated from Erycibe obtusifolia Benth, and its mechanism of action.
Pan R; Gao X; Lu D; Xu X; Xia Y; Dai Y
Int Immunopharmacol; 2011 Dec; 11(12):2007-16. PubMed ID: 21896339
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic effect of chamigrane endoperoxides from a Thai mangrove-derived fungus.
Chokpaiboon S; Sommit D; Bunyapaiboonsri T; Matsubara K; Pudhom K
J Nat Prod; 2011 Oct; 74(10):2290-4. PubMed ID: 21954864
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic activity of lupeol from Bombax ceiba.
You YJ; Nam NH; Kim Y; Bae KH; Ahn BZ
Phytother Res; 2003 Apr; 17(4):341-4. PubMed ID: 12722136
[TBL] [Abstract][Full Text] [Related]
12. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenic attributes by decursin in endothelial cells and ex vivo rat aortic ring angiogenesis model.
Bhat TA; Moon JS; Lee S; Yim D; Singh RP
Indian J Exp Biol; 2011 Nov; 49(11):848-56. PubMed ID: 22126016
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of glycolipids from spinach on in vitro and ex vivo angiogenesis.
Matsubara K; Matsumoto H; Mizushina Y; Mori M; Nakajima N; Fuchigami M; Yoshida H; Hada T
Oncol Rep; 2005 Jul; 14(1):157-60. PubMed ID: 15944783
[TBL] [Abstract][Full Text] [Related]
15. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
16. Geniposide, an anti-angiogenic compound from the fruits of Gardenia jasminoides.
Koo HJ; Lee S; Shin KH; Kim BC; Lim CJ; Park EH
Planta Med; 2004 May; 70(5):467-9. PubMed ID: 15124095
[TBL] [Abstract][Full Text] [Related]
17. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.
Dong Y; Lu B; Zhang X; Zhang J; Lai L; Li D; Wu Y; Song Y; Luo J; Pang X; Yi Z; Liu M
Carcinogenesis; 2010 Dec; 31(12):2097-104. PubMed ID: 20732905
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic 3,4-seco-cycloartane triterpenes from the exudate of Gardenia tubifera.
Nuanyai T; Chokpaiboon S; Vilaivan T; Pudhom K
J Nat Prod; 2010 Jan; 73(1):51-4. PubMed ID: 20028108
[TBL] [Abstract][Full Text] [Related]
20. Piper longum inhibits VEGF and proinflammatory cytokines and tumor-induced angiogenesis in C57BL/6 mice.
Sunila ES; Kuttan G
Int Immunopharmacol; 2006 May; 6(5):733-41. PubMed ID: 16546703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
